The Enterprise Value as of December 2025 (TTM) for Endonovo Therapeutics, Inc. (ENDV) is 6.93M

According to Endonovo Therapeutics, Inc.’s latest financial reports and current stock price. The company's current Enterprise Value is 6.93M. This represents a change of 2.38% compared to the average of 6.77M of the last 4 quarters.

Endonovo Therapeutics, Inc. (ENDV) Historical Enterprise Value (quarterly & annually)

How has ENDV Enterprise Value performed in the past?

The mean historical Enterprise Value of Endonovo Therapeutics, Inc. over the last ten years is 5.48B. The current 6.93M Enterprise Value has changed -87.37% with respect to the historical average. Over the past ten years (40 quarters), ENDV's Enterprise Value was at its highest in in the March 2016 quarter at 46.46B. The Enterprise Value was at its lowest in in the September 2024 quarter at 5.99M.

Endonovo Therapeutics, Inc. (ENDV) Enterprise Value by Quarter and Year

Discovering the peaks and valleys of Endonovo Therapeutics, Inc. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Endonovo Therapeutics, Inc. (ENDV) Average Enterprise Value

How has ENDV Enterprise Value performed in the past?

The current Enterprise Value of Endonovo Therapeutics, Inc. (ENDV) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

Endonovo Therapeutics, Inc. (ENDV) Enterprise Value vs. Peers

How is ENDV’s Enterprise Value compared to its peers?

Endonovo Therapeutics, Inc.’s Enterprise Value is greater than Itoco Inc. (262.41K), greater than Baseline Productions, Inc. (238.44K), greater than GeneLink, Inc. (-147867.00), greater than Medical Imaging Corp. (3.82M), less than Amarantus BioScience Holdings, Inc. (19.18M), greater than Affymax, Inc. (-5555761.00), less than Nutranomics, Inc. (15.30M), greater than CNBX Pharmaceuticals Inc. (1.36M), greater than Veritas Farms, Inc. (4.55M), greater than West Island Brands Inc. (3.73M),

Build a custom stock screener for Endonovo Therapeutics, Inc. (ENDV) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Endonovo Therapeutics, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Endonovo Therapeutics, Inc. (ENDV) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Endonovo Therapeutics, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.